United-Guardian Reports Higher First Quarter Sales and Earnings

Wednesday, May 10, 2017 1:00 PM UTC

HAUPPAUGE, N.Y., May 10, 2017 -- United-Guardian, Inc. (NASDAQ:UG) reported today that an increase in demand for its personal care and pharmaceutical products resulted in a 23% increase in sales and a 21% increase in net income for the first quarter of 2017 compared with the same quarter last year. Sales for the period increased from $2,330,576 in the first quarter of 2016 to $2,872,722 in this year’s first quarter, and net income rose from $525,091 ($0.11 per share) to $634,435 ($0.14 per share).

Ken Globus, President of United-Guardian, stated, “As a result the resumption of shipments of one of our Lubrajel^® products to China, sales of our personal care products increased by 37% in the first quarter of this year. This increase, along with a 53% increase in revenue from our pharmaceutical products (partially offset by some lower European and medical product sales), resulted in a significant increase in sales for the first quarter of 2017. The increase in pharmaceutical revenue was due to sales of our new single-dose form of Renacidin^®, our most important pharmaceutical product, which was not yet available for sale in the first quarter of 2016. We are optimistic that we will be able to continue to increase sales as we bring some of our new personal care products to market.”

United-Guardian is a manufacturer of cosmetic ingredients, personal and health care products, pharmaceuticals, and specialty industrial products.

NOTE: This press release contains both historical and "forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements about the company’s expectations or beliefs concerning future events, such as financial performance, business prospects, and similar matters, are being made in reliance upon the “safe harbor” provisions of that Act. Such statements are subject to a variety of factors that could cause our actual results or performance to differ materially from the anticipated results or performance expressed or implied by such forward-looking statements. For further information about the risks and uncertainties that may affect the company’s business please refer to the company's reports and filings with the Securities and Exchange Commission.


RESULTS FOR THE QUARTERS ENDED MARCH 31, 2017 and MARCH 31, 2016*

STATEMENTS OF INCOME (UNAUDITED)
		THREE MONTHS ENDED MARCH 31,
			2017			2016
	Sales:
	Gross sales	$	2,872,722		$	2,330,576
	Sales rebates and allowances		(86,334	)		(68,000	)
	Net Sales		2,786,388			2,262,576

	Costs and expenses:
	Cost of sales		1,264,096			897,725
	Operating expenses		463,480			467,556
	Research and development		189,729			177,566
	Total costs and expenses		1,917,305			1,542,847
	Income from operations		869,083			719,729

	Other income:
	Investment income		52,872			43,312
	Income before provision for income taxes		921,955			763,041

	Provision for income taxes		287,520			237,950
	Net income	$	634,435		$	525,091

	Earnings per common share (Basic and Diluted)	$	0.14		$	0.11

	Weighted average shares – basic and diluted		4,594,319			4,594,319

_* Additional financial information can be found at the company’s web site at www.u-g.com.

Contact:  

Robert S. Rubinger
Public Relations
(631) 273-0900

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

United-Guardian Reports Higher First Quarter Sales and Earnings

Editor's Picks

Welcome to EconoTimes